CeLLife Technologies Secures $4 Million in Latest Seed Funding Round

CeLLife Technologies secured $4 million in its latest Seed, adding another data point to the Healthcare & Life Sciences funding market.

CeLLife Technologies Raises $4 million in Funding

CeLLife Technologies is a Digital Health company focused on Scale Battery Quality and Health Intelligence Platform.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

CeLLife Technologies operates in Healthcare & Life Sciences. CeLLife Technologies's Seed round shows investors are still backing digital health platforms with real scale narratives. At $4M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Scale Battery Quality and Health Intelligence Platform

Looking Ahead

CeLLife Technologies Closes €4 Million Post-Seed Round to Scale Battery Quality and Health Intelligence Platform

Source reference: original announcement/article.